Get started
Author

J. Kreuzer

Observed names: J KREUZER, J Kreuzer, J. KREUZER, JOERG KREUZER
Institutions: Boston University, University Medical Center Groningen, Thomas Jefferson University, Brown University, Thrombosis and Atherosclerosis Research Institute, Boehringer Ingelheim (United States), McMaster University
Observed institutions: Boston University, Goethe University Frankfurt, Beth Israel Deaconess Medical Center, University Medical Center Groningen, Thomas Jefferson University, University of California, Los Angeles, Heidelberg University, Brown University, University Hospital Heidelberg, Cardiovascular Center Bethanien, St. Vincenz-Krankenhaus Limburg, Thrombosis and Atherosclerosis Research Institute, Boehringer Ingelheim (United States), University of Lübeck, McMaster University
OpenAlex ID: A5111493214
Vascular NADPH oxidases: molecular mechanisms of activation
2004 · R BRANDES, J KREUZER · Cardiovascular Research · 412
Pathology of atheromatous lesions in inbred and genetically engineered mice. Genetic determination of arterial calcification.
1994 · J H Qiao, P Z Xie, et al. · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · 239
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitors Modify the Inflammatory Response of Human Macrophages and Endothelial Cells Infected With Chlamydia pneumoniae
2000 · H. Kothe, K. Dalhoff, et al. · Circulation · 151
MCP-1 induces activation of MAP-kinases ERK, JNK and p38 MAPK in human endothelial cells
2002 · M WERLE, U SCHMAL, et al. · Cardiovascular Research · 100
Platelet‐derived growth factor activates production of reactive oxygen species by NAD(P)H‐oxidase in smooth muscle cells through Gi1,2
2002 · J. Kreuzer, C. Viedt, et al. · The FASEB Journal · 81
Thrombin-induced MCP-1 Expression Involves Activation of the p22phox-containing NADPH Oxidase in Human Vascular Smooth Muscle Cells
2001 · C. Viedt, K. Nguyen, et al. · Thrombosis and Haemostasis · 77
Chemotaxis of the monocyte cell line U937: Dependence on cholesterol and early mevalonate pathway products
1991 · J KREUZER, J BADER, et al. · Atherosclerosis · 66
Cytokeratins 8 and 18 in smooth muscle cells. Detection in human coronary artery, peripheral vascular, and vein graft disease and in transplantation-associated arteriosclerosis.
1993 · L Jahn, J Kreuzer, et al. · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · 50
Smoothelin is an indicator of reversible phenotype modulation of smooth muscle cells in balloon-injured rat carotid arteries
2002 · Harald Bär, P. Wende, et al. · Basic Research in Cardiology · 41
Ligand-dependent autophosphorylation of the insulin receptor is positively regulated by Gi-proteins
2004 · J. KREUZER, B. NÜRNBERG, et al. · Biochemical Journal · 36
PDF
Influence of the angiotensin converting enzyme inhibitor ramipril on high-sensitivity C-reactive protein (hs-CRP) in patients with documented atherosclerosis
2005 · V. Mitrovic, H. H. Klein, et al. · Zeitschrift für Kardiologie · 32
Adenovirus-assisted lipofection: efficient in vitro gene transfer of luciferase and cytosine deaminase to human smooth muscle cells
1996 · J. Kreuzer, S. Denger, et al. · Atherosclerosis · 27
Fibrinogen promotes monocyte adhesion via a protein kinase C dependent mechanism
1996 · J. Kreuzer, S. Denger, et al. · Journal of Molecular Medicine · 25
Effects of HMG-CoA reductase inhibition on PDGF- and angiotensin II- mediated signal transduction: suppression of c-Jun and c-Fos in human smooth muscle cells in vitro.
1999 · J Kreuzer, L Watson, et al. · PubMed · 20
Initial Results of the Re-verse Ad Trial: Idarucizumab Reverses the Anticoagulant Effects of Dabigatran in Patients in an Emergency Setting of Major Bleeding, Urgent Surgery or Interventions
2015 · C Pollack, J Eikelboom, et al. · Emergency Medicine Journal · 9
Update on anti-coagulation in atrial fibrillation
2011 · J. Kreuzer · QJM · 6
PDF
Impending paradoxical embolism and dynamic left ventricular outflow obstruction in a patient with recurrent pulmonary embolism and secondary pulmonary hypertension
1996 · J. KREUZER, C. E. WEINBRENNER, et al. · European Heart Journal · 6
Initial experience with idarucizumab in dabigatran-treated patients requiring emergency surgery or interventon: interim results from the RE-VERSE AD study
2015 · J. H Levy, Peter Verhamme, et al. · European Heart Journal · 5
Sekundärprävention nach Herzinfarkt: Therapeutische Effizienz – Kosten-Nutzen-Relation
2001 · J. Kreuzer, W. Kübler · Der Internist · 5
Current aspects of gene therapy: implications for vascular interventions
1995 · F. Reifers, J. Kreuzer · Journal of Molecular Medicine · 5
Lipid-lowering therapy and cholesterol levels following acute myocardial infarction: A German study of 5361 patients
2003 · A. Bergmann, J. Schulze, et al. · European Journal of Epidemiology · 4
Protein kinase C activation after cellular adhesion on fibronectin: partial suppression after inhibition of protein isoprenylation.
1997 · J Kreuzer, A Schmidts, et al. · PubMed · 3
Initial results of the re-verse AD trial: idarucizumab reverses the anticoagulant effects of dabigatran in patients in an emergency setting of major bleeding, urgent surgery, or interventions
2015 · Charles V. Pollack, Paul Reilly, et al. · Journal of Thrombosis and Haemostasis · 2
4 Initial Experience With Idarucizumab in Dabigatran-Treated Patients Presenting With Acute Gastrointestinal Hemorrhage: Interim Results from the RE-VERSE AD Study
2015 · C.V. Pollack, F. Gruenenfelder, et al. · Annals of Emergency Medicine · 1
Current management of upper gastrointestinal bleeding.
2011 · A Kirschniak, D Stierle, et al. · PubMed · 1
Works count: 38
Citation count: 1,405
H-index: 14
I10-index: 14
Year
Topic
Type